Jonathan Edwards
"Gibberish"
- Messages
- 5,256
This looks to me pretty unsurprising. People who get multiple cytotoxic agents for lymphoma often develop severe and unusual infections. (This is partly because of the cancer and partly the powerful combination of non-specific drugs like cyclo and is quite different from the situation in autoimmunity.) For someone harbouring borrelia to develop neurological involvement in this context would seem unremarkable. What seems worth a publication is that rituximab might well prevent a major rise in antibody to the borrelia at the time of the spreading infection - making diagnosis of borreliosis by serology particularly inconclusive in this scenario. I think this is the message they want to put across.
There is certainly no suggestion that rituximab is making Lyme better. Unfortunately it may be easy to get the wrong end of the stick - and I think daffodil has had that problem. Treating Lyme with rituximab would be plain crazy, I think.
There is certainly no suggestion that rituximab is making Lyme better. Unfortunately it may be easy to get the wrong end of the stick - and I think daffodil has had that problem. Treating Lyme with rituximab would be plain crazy, I think.